scispace - formally typeset
M

Moinuddin

Researcher at Aligarh Muslim University

Publications -  134
Citations -  3535

Moinuddin is an academic researcher from Aligarh Muslim University. The author has contributed to research in topics: Glycation & DNA. The author has an hindex of 34, co-authored 126 publications receiving 2999 citations. Previous affiliations of Moinuddin include Jawaharlal Nehru Medical College, Aligarh.

Papers
More filters
Journal ArticleDOI

AGEs, RAGEs and s-RAGE; friend or foe for cancer.

TL;DR: The possibility of providing a potential complement to carcinogenesis is very high and the levels of RAGE and s-RAGE may be a useful biomarker of ligand- RAGE pathway activation and cancer.
Journal ArticleDOI

Salicylic acid mitigates salinity stress by improving antioxidant defence system and enhances vincristine and vinblastine alkaloids production in periwinkle [ Catharanthus roseus (L.) G. Don]

TL;DR: A pot experiment was conducted to find out whether the foliar spray of salicylic acid (SA) could successfully ameliorate the adverse effects of salinity stress on periwinkle as discussed by the authors.
Journal ArticleDOI

Genotoxicity and immunogenicity of DNA-advanced glycation end products formed by methylglyoxal and lysine in presence of Cu2+.

TL;DR: The results show structural perturbations in MG-Lys-Cu(2+)-DNA generating new epitopes that render the molecule immunogenic, and genotoxicity of the experimentally generated AGEs was confirmed by comet-assay.
Journal ArticleDOI

Role of Salicylic Acid in Promoting Salt Stress Tolerance and Enhanced Artemisinin Production in Artemisia annua L.

TL;DR: In this paper, the role of salicylic acid (SA) in inducing salinity tolerance was studied in Artemisia annua L., which is a major source of the antimalarial drug artemisinin.
Journal ArticleDOI

Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products.

TL;DR: The inhibition in the formation of glycation reaction reveals that Pyridoxamine is a better antiglycating agent than Metformin at all stages of the glycation (early, intermediate and late stages).